XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Class A and Class B Common Stock
Class A and Class B Common Stock
Shares, beginning of period (in shares) at Jan. 31, 2022         270,451,615
Balance, beginning of period at Jan. 31, 2022 $ 1,650,788 $ 2,271,980 $ 454 $ (621,673) $ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)         3,369,153
Issuance of common stock upon exercise of stock options 8,381 8,381      
Vesting of restricted stock units (in shares)         317,854
Issuance of common stock under employee stock purchase plan (in shares)         405,534
Issuance of common stock under employee stock purchase plan 8,682 8,682      
Vesting of early exercised stock options 18 18      
Issuance of common stock in connection with acquisition (in shares)         6,032,231
Issuance of common stock in connection with acquisition 186,333 186,332     $ 1
Stock-based compensation 74,221 74,221      
Other comprehensive loss (2,467)   (2,467)    
Net loss (186,140)     (186,140)  
Shares, end of period (in shares) at Jul. 31, 2022         280,576,387
Balance, end of period at Jul. 31, 2022 1,739,816 2,549,614 (2,013) (807,813) $ 28
Shares, beginning of period (in shares) at Apr. 30, 2022         272,496,624
Balance, beginning of period at Apr. 30, 2022 1,597,242 2,309,505 (783) (711,507) $ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)         1,350,556
Issuance of common stock upon exercise of stock options 3,291 3,291      
Vesting of restricted stock units (in shares)         291,442
Issuance of common stock under employee stock purchase plan (in shares)         405,534
Issuance of common stock under employee stock purchase plan 8,682 8,682      
Issuance of common stock in connection with acquisition (in shares)         6,032,231
Issuance of common stock in connection with acquisition 186,333 186,332     $ 1
Stock-based compensation 41,804 41,804      
Other comprehensive loss (1,230)   (1,230)    
Net loss (96,306)     (96,306)  
Shares, end of period (in shares) at Jul. 31, 2022         280,576,387
Balance, end of period at Jul. 31, 2022 1,739,816 2,549,614 (2,013) (807,813) $ 28
Shares, beginning of period (in shares) at Jan. 31, 2023         286,763,857
Balance, beginning of period at Jan. 31, 2023 1,656,705 2,663,394 (6,367) (1,000,351) $ 29
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)         5,074,687
Issuance of common stock upon exercise of stock options 13,845 13,845      
Vesting of restricted stock units (in shares)         2,491,451
Issuance of common stock under employee stock purchase plan (in shares)         568,611
Issuance of common stock under employee stock purchase plan 6,416 6,416      
Vesting of early exercised stock options 169 169      
Stock-based compensation 111,195 111,195      
Other comprehensive loss (2,604)   (2,604)    
Net loss (196,407)     (196,407)  
Shares, end of period (in shares) at Jul. 31, 2023         294,898,606
Balance, end of period at Jul. 31, 2023 1,589,319 2,795,019 (8,971) (1,196,758) $ 29
Shares, beginning of period (in shares) at Apr. 30, 2023         291,225,065
Balance, beginning of period at Apr. 30, 2023 1,617,174 2,729,978 (5,613) (1,107,220) $ 29
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)         1,372,895
Issuance of common stock upon exercise of stock options 4,083 4,083      
Vesting of restricted stock units (in shares)         1,732,035
Issuance of common stock under employee stock purchase plan (in shares)         568,611
Issuance of common stock under employee stock purchase plan 6,416 6,416      
Vesting of early exercised stock options 120 120      
Stock-based compensation 54,422 54,422      
Other comprehensive loss (3,358)   (3,358)    
Net loss (89,538)     (89,538)  
Shares, end of period (in shares) at Jul. 31, 2023         294,898,606
Balance, end of period at Jul. 31, 2023 $ 1,589,319 $ 2,795,019 $ (8,971) $ (1,196,758) $ 29